Inventiva Sa has released a press release.
Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026
Earlier from Inventiva Sa
- Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
- Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH
- Inventiva Appoints Chris Benecchi as Chief Operating Officer
- Inventiva nomme Chris Benecchi au poste de Chief Operating Officer